Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma Article

Happold, Caroline, Gorlia, Thierry, Chinot, Olivier et al. (2016). Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma . JOURNAL OF CLINICAL ONCOLOGY, 34(7), 731-+. 10.1200/JCO.2015.63.6563

Open Access International Collaboration

cited authors

  • Happold, Caroline; Gorlia, Thierry; Chinot, Olivier; Gilbert, Mark R; Nabors, L Burt; Wick, Wolfgang; Pugh, Stephanie L; Hegi, Monika; Cloughesy, Timothy; Roth, Patrick; Reardon, David A; Perry, James R; Mehta, Minesh P; Stupp, Roger; Weller, Michael

sustainable development goals

authors

publication date

  • March 1, 2016

webpage

published in

keywords

  • BEVACIZUMAB
  • BRAIN-TUMORS
  • CHEMOTHERAPY
  • COMBINATION
  • EPILEPSY
  • IRRADIATION
  • Life Sciences & Biomedicine
  • OPEN-LABEL
  • Oncology
  • RADIATION-THERAPY
  • STANDARD TREATMENT
  • Science & Technology
  • TEMOZOLOMIDE

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 731

end page

  • +

volume

  • 34

issue

  • 7